Drug metabolism studies in the newborn infant and children using an oral erythromycin breath test

Paediatric and Perinatal Drug Therapy

Volumn 7, Issue 4, 2006, Pages 172-177

  Cocking, Caroline ^a   Webster, Elizabeth ^a   McIntyre, John ^a   Preston, Tom ^b   Choonara, Imti ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b SCOTTISH UNIVERSITIES ENVIRONMENTAL RESEARCH CENTRE   (United Kingdom)

Author keywords

Children; CYP3A4; Enzyme induction; Erythromycin; Neonate

Indexed keywords

ALUMINUM MAGNESIUM HYDROXIDE; CARBAMAZEPINE; CARBON DIOXIDE; CYTOCHROME P450 3A; ERYTHROMYCIN;

ADOLESCENT; ARTICLE; ARTIFICIAL VENTILATION; BREATH ANALYSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; ENZYME ACTIVITY; EPILEPSY; HUMAN; INFANT; NASOGASTRIC TUBE; NEWBORN;

EID: 33947325133     PISSN: 14630095     EISSN: None     Source Type: Journal    
DOI: 10.1185/146300906X148576     Document Type: Article

References (17)

1. Parker AC, Preston T, Heaf D, Kitteringham NR, Choonara I. Inhibition of caffeine metabolism by ciprofloxacin in children with cystic fibrosis as measured by the caffeine breath test. Br J Clin Pharmacol 1994;38:573-576
2. Parker AC, Pritchard P, Preston T, Dalzell AM, Choonara I. Lack of inhibitory effect of cimetidine on caffeine metabolism in children using the caffeine breath test. Br J Clin Pharmacol 1997;43:467-470
3. Parker AC, Pritchard P, Preston T, Choonara I. Induction of CYP1A2 activity by carbamazepine in children using the caffeine breath test. Br J Clin Pharmacol 1998;45:176-178
4. Lambert GH, Schoeller DA, Kotake AN, Flores C, Hay D. The effect of age and sexual maturation on the caffeine breath test. Dev Pharmacol Ther 1986;9:375-388
5. 2 breath test. Dev Pharmacol Ther 1989;12:90-95
6. 2 breath test. Pediatr Res 1988;23:632-636
7. Parker AC, Pritchard P, Preston T, Smyth RL, Choonara I. Enhanced drug metabolism in young children with cystic fibrosis. Arch Dis Child 1997;77:239-241
8. 2 breath tests as monitors of the cytochrome P450 dependent mixed function monooxygenase system. Prog Clin Biol Res 1983;135:119-145
9. 2 breath tests: methodology and fundamental considerations. J Lab Clin Med 1977;90:412-421
10. Webster E, McIntyre J, Choonara I, Preston T. The caffeine breath test and CYP1A2 activity in children. Paed Perinat Drug Ther 2002;5:28-33
11. Chiou WL, Jeong HY, Wu TC, Ma C. Use of the erythromycin breath test for in vivo assessments of cytochrome P4503A activity and dosage individualization. Clin Pharmacol Ther 2001;70:305-310
12. Rivory LP, Slaviero KA, Hoskins JM, Clarke SJ. The erythromycin breath test for the prediction of drug clearance. Clin Pharmacokinet 2001;40: 151-158
13. Paine MF, Wagner DA, Hoffmaster KA, Watkins PB. Cytochrome P450 3A4 and P-glycoprotein mediate the interaction between an oral erythromycin breath test and rifampin. Clin Pharmacol Ther 2002;72:524-535
14. Preston T, McMillan DC. Rapid sample throughput for biomedical stable isotope tracer studies. Biomed Environ Mass Spectrom 1988;16:229-235
15. Bertilsson L, Tybring G, Widen J, Chang M, Tomson T. Carbamazepine treatment induces the CYP3A4 catalysed sulphoxidation of omeprazole, but has no or less effect on hydroxylation via CYP2C19. Br J Clin Pharmacol 1997;44:186-189
16. 13C breath tests. Rap Comm Mass Spectrom 2000;14:1321-1324
17. de Wildt SN, Johnson TN, Choonara I. The effect of age on drug metabolism. Paed Perinat Drug Ther 2003;5:101-106